Skip to main content
    C

    Collegium Pharmaceutical Inc (COLL)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $23.18
    +0.67 (+2.98%)

    Market Cap: $700.92M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(26/39)
    Avg Surprise
    +11.01%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$1.79
    Range$1.49 - $1.97
    7 analysts
    EPS RevisionsNo revisions (7d)
    0
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$2.08-13.7%
    60d ago$1.87-4.0%
    30d ago$1.86-3.7%
    7d ago$1.81-1.2%
    Current$1.79
    Revenue Consensus
    $216M
    Range$214M - $221M
    7 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.24
    Range$1.57 - $2.61
    7 analysts
    Revenue Consensus
    $232M
    Range$228M - $236M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$2.24---
    Sep 26EST
    		-$1.79---
    Jun 26
    Reported Aug 6
    		$1.57$1.48+6.08%Beat+6.8%
    Mar 26
    Reported May 7
    		$1.76$1.52+15.79%Beat+18.1%
    Dec 25
    Reported Feb 26
    		$1.85$2.01-7.96%Miss+4.5%
    Sep 25
    Reported Nov 6
    		$2.25$1.86+20.97%Beat+39.8%
    Jun 25
    Reported Aug 7
    		$1.47$1.43+2.80%Beat-9.3%
    Mar 25
    Reported May 8
    		$1.49$1.45+2.76%Beat+2.8%
    Dec 24
    Reported Feb 27
    		$1.77$1.54+15.12%Beat+12.0%
    Sep 24
    Reported Nov 7
    		$1.61$1.59+1.26%Beat+20.1%
    Jun 24
    Reported Aug 8
    		$1.62$1.49+8.72%Beat+28.6%
    Mar 24
    Reported May 9
    		$1.45$1.47-1.36%Miss+9.8%
    Dec 23
    Reported Feb 22
    		$1.58$1.25+26.40%Beat+852.4%
    Sep 23
    Reported Nov 7
    		$1.34$1.24+8.06%Beat+21.8%
    Jun 23
    Reported Aug 3
    		$1.26$1.22+3.28%Beat+4.1%
    Mar 23
    Reported May 4
    		$1.32$1.51-12.58%Miss+45.1%
    Dec 22
    Reported Feb 23
    		$-0.21$-0.14-50.00%Miss+58.8%
    Sep 22
    Reported Nov 3
    		$1.10$1.38-20.29%Miss+41.0%
    Jun 22
    Reported Aug 4
    		$1.21$1.44-15.97%Miss+49.4%
    Mar 22
    Reported May 10
    		$0.91$0.90+1.11%Beat-5.2%
    Dec 21
    Reported Feb 24
    		$-0.51N/A-149.04%Miss-355.0%
    Sep 21
    Reported Nov 4
    		$0.78$0.96-18.75%Miss-24.3%
    Jun 21
    Reported Aug 5
    		$0.81$0.95-14.74%Miss-14.7%
    Mar 21
    Reported May 6
    		$0.96$1.00-4.00%Miss+9500.0%
    Dec 20
    Reported Feb 25
    		$0.20$0.39-48.72%Miss+25.0%
    Sep 20
    Reported Nov 5
    		$1.03$0.90+14.44%Beat+1960.0%
    Jun 20
    Reported Aug 5
    		$0.95$0.86+10.47%Beat+955.6%
    Mar 20
    Reported May 7
    		$0.01N/A-97.56%Miss+120.0%
    Dec 19
    Reported Feb 27
    		$0.16$0.10+60.00%Beat-40.7%
    Sep 19
    Reported Nov 6
    		$0.05$0.03+66.67%Beat+120.0%
    Jun 19
    Reported Aug 7
    		$0.09$-0.04+325.00%Beat+160.0%
    Mar 19
    Reported May 8
    		$-0.05N/A+66.67%Beat+91.2%
    Dec 18
    Reported Feb 27
    		$0.27$-0.35+177.14%Beat+150.0%
    Sep 18
    Reported Nov 8
    		$-0.25$-0.12-108.33%Miss+44.4%
    Jun 18
    Reported Aug 8
    		$-0.15N/A+54.55%Beat+79.2%
    Mar 18
    Reported May 9
    		$-0.57$-0.65+12.31%Beat+27.8%
    Dec 17
    Reported Mar 7
    		$-0.54$-0.57+5.26%Beat+47.1%
    Sep 17
    Reported Nov 8
    		$-0.45$-0.73+38.36%Beat-
    Jun 17
    Reported Aug 9
    		$-0.72$-0.80+10.00%Beat-
    Mar 17
    Reported May 10
    		$-0.79$-1.00+21.00%Beat-
    Dec 16
    Reported Mar 9
    		$-1.02$-1.07+4.67%Beat-

    Key Metrics

    Valuation
    P/E Ratio3.12EV/EBITDA4.38x
    Price/FCF2.29xFCF Yield43.63%
    Profitability
    Profit Margin5.93%Operating Margin5.65%
    ROE17.60%ROIC7.21%
    Financial Health
    Debt/Equity3.55xInterest Coverage1.70x
    Current Ratio1.03xQuick Ratio0.84x
    Trading Statistics
    Beta0.73Avg Volume840.91K
    52-Week High$50.7952-Week Low$21.43

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$22.12
    SMA 20$22.30
    SMA 50$24.31
    SMA 200$34.53
    EMA 10$22.29
    EMA 20$22.55
    EMA 50$24.87
    EMA 200$31.60

    MACD

    Line: -0.63Signal: -0.93Hist: 0.31

    ADX

    ADX: 34.8+DI: 22.6-DI: 17.2

    Aroon & PSAR

    Aroon Up100.0
    Aroon Down60.0
    PSAR$21.43

    Bollinger Bands

    Upper Band$23.20
    Lower Band$21.39
    %B Position810%(Upper)
    Band Width0.99

    RSI (14-Day)

    Neutral
    52.0

    Momentum Oscillators

    Stoch %K44.9
    Stoch %D32.5
    Williams %R-33.0
    ROC (10d)6.1%
    Momentum1.34
    CCI (20d)196.7
    MFI (14d)45.7

    Volatility Measures

    ATR (14d)$0.89(3.8%)
    StdDev (20d)0.45
    Hist Vol26.2%(Moderate)

    Volume Flow

    VWAP$23.43
    OBV11.8M
    AD Line-14.4M
    CMF (20d)-0.041

    Volume Metrics

    Avg Vol (20d)831.9K
    Vol Ratio1.2x
    VWMA (20d)$22.34

    Pivot Points

    R3$23.98
    R2$23.27
    R1$22.89
    Pivot Point$22.18
    S1$21.80
    S2$21.09
    S3$20.71

    Advanced Oscillators

    TSI-28.18
    Ultimate Osc50.5
    KST-84.65

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$199.88M$193.52M$205.45M$209.36M$188.00M$177.76M$181.95M$159.30M$145.28M$144.92M$149.75M$136.71M
    Cost of Revenue$89.59M$76.27M$77.07M$80.19M$79.62M$80.43M$83.66M$62.51M$54.47M$53.47M$55.12M$56.40M
    Gross Profit$110.29M$117.25M$128.38M$129.17M$108.38M$97.32M$98.29M$96.79M$90.81M$91.46M$94.63M$80.31M
    Operating Expenses$106.59M$86.35M$67.62M$67.08M$73.28M$75.64M$60.18M$61.95M$43.34M$41.98M$32.94M$35.30M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$106.59M$86.35M$67.64M$67.10M$73.64M$76.42M$63.09M$61.95M$43.34M$41.98M$32.94M$35.30M
    Operating Income$3.70M$30.90M$60.76M$62.09M$35.10M$21.69M$38.11M$34.84M$47.47M$49.47M$61.69M$45.01M
    Interest Income$2.29M$3.71M$3.56M$3.12M$2.38M$2.23M$1.81M$3.28M$4.40M$4.49M$4.30M$4.54M
    Interest Expense$19.52M$15.86M$35.29M$21.77M$20.46M$20.79M$22.65M$22.54M$22.77M$17.34M$19.28M$20.77M
    Income Before Tax$-13,532,000$18.74M$29.04M$43.44M$17.02M$3.12M$17.27M$15.58M$29.10M$36.62M$46.71M$28.78M
    Income Tax Expense$1.52M$4.24M$12.07M$11.93M$5.04M$705,000$4.73M$6.25M$9.49M$8.91M$14.77M$8.15M
    Net Income$-15,051,000$14.50M$16.96M$31.51M$11.98M$2.42M$12.54M$9.34M$19.61M$27.71M$31.94M$20.63M
    EBITDA$69.50M$87.47M$118.17M$119.71M$92.80M$79.29M$95.67M$77.28M$83.82M$86.27M$98.55M$83.72M
    EBIT$3.70M$30.90M$60.76M$62.09M$35.10M$21.69M$38.11M$34.84M$47.47M$49.47M$61.69M$45.01M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about COLL

    News

    Barclays Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $48

    Barclays has reiterated its Buy rating on Collegium Pharmaceutical (COLL.US), maintaining a target price of $48. This indicates the firm's continued confidence in the company's stock performance.

    Moomoo•10/16/26•Bullish

    Collegium Pharmaceutical stock has a November 5 earnings date

    Collegium Pharmaceutical (COLL) is scheduled to report its third-quarter 2026 earnings on November 5, 2026, before the market opens. As of October 15, 2026...

    ad-hoc-news.de•10/15/26•Somewhat-Bullish

    COLL5756983 Bond Profile: Coupon and Redemption

    This article provides a detailed profile of the COLL5756983 bond issued by Collegium Pharmaceutical, Inc. It outlines key facts such as the issuer, issue and maturity dates, face value...

    TradingView•10/11/26•Neutral

    Behavioral Patterns of COLL and Institutional Flows

    This article analyzes Collegium Pharmaceutical Inc. (NASDAQ: COLL), identifying a near-term neutral sentiment amidst mid and long-term weakness. It highlights an exceptional risk-reward setup targeting a 29.5% gain...

    Stock Traders Daily•10/10/26•Neutral

    Collegium Pharmaceutical, Inc. (COLL) Stock forecasts

    This article provides a stock forecast for Collegium Pharmaceutical, Inc. (COLL) from Argus, dated October 7, 2026. It identifies Collegium Pharmaceutical as a specialty pharmaceutical company and indicates a current...

    Yahoo Finance UK•10/9/26•Neutral

    COLL Valuation and Fair Value

    P/E
    3.1x
    Forward P/E
    3.4x
    EV/EBITDA
    4.4x
    P/FCF
    2.3x
    PEG
    0.0x
    P/B
    2.4x
    See GNG's fair value

    COLL Profitability: Margins, ROIC and FCF

    Gross margin
    60.0%
    Operating margin
    5.7%
    Net margin
    5.9%
    ROIC
    7.2%
    ROE
    17.6%
    FCF margin
    40.6%
    FCF yield
    43.6%

    COLL Competitors

    CompanyTicker
    Immix Biopharma IncIMMX
    Adlai Nortye Ltd. American Depositary SharesANL
    Enhabit Inc.EHAB
    Verastem IncVSTM
    Candel Therapeutics IncCADL
    Sana Biotechnology IncSANA
    Geron CorporationGERN
    Annexon IncANNX

    Sector: Healthcare

    COLL Analyst Ratings

    Consensus
    Buy
    Analysts
    8
    Strong Buy
    2
    Buy
    5
    Hold
    1
    Sell
    0
    Strong Sell
    0

    COLL Bull Case vs Bear Case

    Bull case

    • COLL converts 40.6% of revenue into free cash flow.
    • COLL beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 87.5% of COLL's analyst ratings are Buy or Strong Buy.

    Bear case

    • COLL has a debt-to-equity ratio of 3.5x.

    COLL Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    7.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $1.79
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 4 down

    Frequently Asked Questions About COLL

    Does COLL pay dividends?

    Collegium Pharmaceutical Inc (COLL) does not currently pay a regular dividend.

    What is COLL's P/E ratio?

    Collegium Pharmaceutical Inc has a price-to-earnings (P/E) ratio of 3.12.

    What is COLL's market cap?

    Collegium Pharmaceutical Inc (COLL) has a market capitalization of $700.92M with a current stock price of $23.18.

    Related stocks

    Sector: Healthcare

    All stocks starting with C

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In